The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| USNA | -52.35% | -75.45% | -24.49% | +3,047% |
| S&P | +13.96% | +91.24% | +13.85% | +1,127% |
USANA Health Sciences, Inc. develops and manufactures nutritional, personal care and weight-management products. It operates under the following segments: USANA Nutritionals, USANA Foods, Personal Care and Skincare, and All Other. The firm's brands include Procosa and MagneCal D. The company was founded by Myron W. Wentz in September 1992 and is headquartered in Salt Lake City, UT.
Sales and earnings fell for the global cellular nutrition company in Q3, but it still managed to beat Wall Street expectations.
The nutrition company reported mainly bad news with its Q2 earnings update.
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $213.67M | 6.7% |
| Gross Profit | $156.94M | -0.3% |
| Gross Margin | 73.45% | -5.2% |
| Market Cap | $503.39M | -30.3% |
| Market Cap / Employee | $0.30M | 0.0% |
| Employees | 1.7K | -5.6% |
| Net Income | -$6.66M | -162.8% |
| EBITDA | $10.79M | -49.0% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $145.35M | -60.2% |
| Inventory | 90.8 | 41.9% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $0.00M | 0.0% |
| Short Term Debt | $0.00M | 0.0% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Return On Assets | 2.43% | -6.1% |
| Return On Invested Capital | 18.33% | -4.0% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$5.16M | -119.0% |
| Operating Free Cash Flow | -$1.96M | -106.6% |
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Earnings | 16.30 | 15.21 | 17.27 | 32.05 | 139.03% |
| Price to Book | 1.28 | 0.97 | 1.08 | 0.95 | -32.83% |
| Price to Sales | 0.80 | 0.61 | 0.64 | 0.57 | -31.88% |
| Price to Tangible Book Value | 1.41 | 2.18 | 2.41 | 2.06 | 33.18% |
| Price to Free Cash Flow TTM | 13.39 | 10.79 | 11.32 | 27.92 | 153.22% |
| Enterprise Value to EBITDA | 42.11 | 16.50 | 18.24 | 39.85 | 135.06% |
| Free Cash Flow Yield | 7.5% | 9.3% | 8.8% | 3.6% | -60.51% |
| Return on Equity | 7.8% | 6.8% | 6.5% | 3.2% | -70.44% |
| Total Debt | $39.20M | $23.00M | $0.00M | $0.00M | - |
No podcast episodes available.
USNA earnings call for the period ending June 30, 2022.
USNA earnings call for the period ending March 31, 2022.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
